Bicara Therapeutics BCAX Net unrealized debt securities gains (losses), net of tax
Net unrealized debt securities gains (losses), net of tax at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent.
The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bicara Therapeutics's net unrealized debt securities gains (losses), net of tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bicara Therapeutics's net unrealized debt securities gains (losses), net of tax?
- Bicara Therapeutics (BCAX) reported net unrealized debt securities gains (losses), net of tax of -$486K in Q1 2026.
- What does net unrealized debt securities gains (losses), net of tax mean?
- The net change in the fair value of debt securities classified as available-for-sale, excluding any realized gains or losses. This metric captures market-driven fluctuations in the value of the company's investment portfolio that are not yet recognized in net income. It provides insight into the volatility and unrealized performance of the firm's liquid asset holdings.